BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
 | 
Aug 19, 2013
 |  BC Week In Review  |  Company News  |  Deals

Adamis, 3M deal

Adamis will acquire exclusive, worldwide rights to use 3M's Taper Dry Powder Inhaler (DPI) technology in all indications in the dry powder inhalation field. Adamis plans to use the technology, which stores APIs on a microstructured carrier tape, to develop a branded generic version of Advair fluticasone...

Read the full 224 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >